Taiflex Scientific revenue and financials
$304.50Change from previous close: +3.05%Absolute change: +$9.00
In the fiscal year ended December 2025, Taiflex Scientific reported revenue of $10.61B (+6.75% year over year). Net income was $535.12M, a net margin of 5.0%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +6.75%
- 2025 vs 2024
- Net income growth
- −9.73%
- 2025 vs 2024
- Net margin
- 5.0%
- 2024: 6.0%
Financial data
Amounts in millions of TWD; per-share values in TWD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | 707 | 1,421 | 1,272 | 1,142 | — |
| Depreciation and amortization | 546 | 530 | 459 | 432 | — |
| Capital expenditure | -596 | -701 | -1,016 | -981 | — |
| Investing cash flow | -210 | -426 | -985 | -688 | — |
| Financing cash flow | -519 | -165 | -568 | -1,512 | — |
| Dividends paid | -641 | -209 | -523 | -523 | — |
| Debt issued | 83.0 | 125 | 7.5 | 0.0 | — |
| Debt repaid | -19.5 | -37.6 | -36.1 | -970 | — |
| Effect of exchange rates | 9.7 | 94.2 | -18.1 | 52.7 | — |
| Net change in cash | -20.9 | 830 | -281 | -1,059 | — |
| Free cash flow | 111 | 720 | 255 | 160 | — |